Kiwilad, you make some good points and my sentiments are about the same as yours. However I'd be slightly more positive about two of your comments.
Firstly I'm not too worried about the loss of two managers. My assumption is that they weren't needed and I'd rather they left than continue to be paid. Over the last year the company has, separately, made a couple of new and well respected appointments.
Secondly, previous comment about needing say 60m to get to commercialisation. I think that's a good position to be in - if this were a drug development company it would be needing several hundred million. This is equivalent to a drug that is well through phase 3 with an ongoing good set of results.
I still don't understand the downward pressure on the SP. And they are going to have to be smart to raise funds. Time will tell.
Malmanu - if I thought a company couldn't run a chook raffle I wouldn't be holding shares in it. If you're so negative why hold any further?
- Forums
- ASX - By Stock
- SHC
- Sunshine Heart Price Target Cut to $12.00 (SSH)
Sunshine Heart Price Target Cut to $12.00 (SSH), page-20
-
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SHC (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online